Related Experiment Video
Updated: Aug 20, 2025

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
Association between COVID-19 and subsequent vascular events in primary care patients in Germany
S Zappacosta1, A Cascarano2, M Konrad3
1Real World Solutions, IQVIA, Basel, Switzerland; University of Paris Cité, Comparative Effectiveness Research, Paris, France.
Insights
COVID-19 diagnosis did not increase the risk of vascular events (VE) compared to respiratory tract infections (RTI). This retrospective study found no significant association overall, with a slight exception in older adults for cardiovascular events.
Area of Science:
- Cardiovascular epidemiology
- Infectious disease outcomes
- Public health research
Background:
- The COVID-19 pandemic has raised concerns about long-term health consequences, including vascular events.
- Understanding the comparative risk of vascular events following COVID-19 versus other respiratory infections is crucial for patient management and public health strategies.
Purpose of the Study:
- To investigate the association between a COVID-19 diagnosis and the risk of a first-ever vascular event (VE).
- To compare this risk with that observed in patients diagnosed with respiratory tract infections (RTI).
Main Methods:
- Retrospective cohort study utilizing data from the Disease Analyzer Database (IQVIA) in Germany.
- Inclusion of patients aged ≥18 years with at least one practice visit during the index period.
- Propensity score matching was used to create comparable cohorts of COVID-19 and RTI patients.
- Kaplan-Meier curves and Poisson models were employed for time-to-event analysis and incidence rate calculations.
Main Results:
- A total of 58,904 patients were matched between the COVID-19 and RTI cohorts.
- No significant association was found between COVID-19 diagnosis and increased VE incidence in females or males.
- Overall, no significant association was observed across age categories, except for a decreased risk of cardiovascular VE in individuals aged ≥70 years (IRR: 0.78 [0.67-0.94]).
Conclusions:
- COVID-19 diagnosis was not associated with an increased risk of developing vascular events compared to RTI diagnosis in this German cohort.
- These findings suggest that COVID-19 may not pose a higher vascular risk than other respiratory infections.
- Further research across diverse healthcare settings and regions is recommended to validate these preliminary findings.
Objectives:
The aim of this study was to investigate the relationship between COVID-19 diagnosis and the risk of developing a first-ever vascular event (VE) compared with the same risk in those with respiratory tract infection (RTI).
Study Design:
This was a retrospective cohort study.
Methods:
This study using data from Disease Analyzer Database (IQVIA) included patients aged ≥18 years with at least one visit to a German practice during the index period. VEs were defined as cardiovascular or cerebrovascular events. Two cohorts were created: patients with a diagnosis of COVID-19 and those diagnosed with RTI. These were matched using propensity scores. Kaplan-Meier curves were created for the purposes of time to event analysis. A Poisson model was used to calculate incidence rates and derive incidence rate ratios (IRRs).
Results:
A total of 58,904 patients were matched. There was no significant association between COVID-19 diagnosis and increased incidence of VE events among females (IRR [95% confidence interval (CI)]: 0.96 [0.82-1.11] and 1.30 [0.88-1.81]) or males (IRR, 95% CI: 0.91 [0.78-1.05] and 1.13 [0.80-1.62]). Overall, no significant association between COVID-19 diagnosis and incidence of VE was observed across age categories except for cardiovascular vascular events in the age category ≥70 years (IRR [95% CI]: 0.78 [0.67-0.94]).
Conclusions:
Overall, our study suggests that COVID-19 diagnosis was not associated with an increased risk of developing VE compared with RTI diagnosis. However, further research in a variety of healthcare settings and regions is needed to confirm these preliminary findings from our cohort, which is a good reflection of routine clinical practice in Germany.
More Related Videos
10:11Fundus Photography as a Convenient Tool to Study Microvascular Responses to Cardiovascular Disease Risk Factors in Epidemiological Studies
Published on: October 22, 2014
06:04Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome
Published on: September 27, 2024
Related Concept Videos
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis III: Interprofessional Care
Rheumatic Heart Disease I: Introduction